橘红胶囊联合阿奇霉素治疗肺炎支原体肺炎患儿痰热闭肺证临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R725.6

基金项目:


Clinical Study on Juhong Capsules Combined with Azithromycin for Children with Mycoplasma Pneumoniae Pneumonia with Syndrome of Phlegm-Heat Blocking Lung
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察橘红胶囊联合阿奇霉素治疗肺炎支原体肺炎(MPP) 患儿痰热闭肺证的疗效以及对血 清Toll 样受体4 (TLR4)、髓样分化因子88 (MyD88)、核转录因子κB (NF-κB) 水平的影响。方法:选取 MPP患儿82例,按随机数字表法分为对照组和观察组各41例。对照组予阿奇霉素序贯方案治疗,观察组在对 照组基础上予橘红胶囊治疗,连续治疗2周。比较2组临床疗效、症状体征消失时间、痰热闭肺证各项评分、 血清T细胞亚群以及血清TLR4、MyD88、NF-κB水平。结果:2周疗程后,观察组总有效率为97.56%,高于对 照组80.49%(P<0.05)。观察组退热、肺湿啰音消除、咳嗽消除时间均短于对照组(P<0.05)。治疗后,2组 痰热闭肺证各项评分较治疗前降低(P<0.05),且观察组痰热闭肺证各项评分低于对照组(P<0.05)。治疗 后,2组CD4+、CD4+/CD8+较治疗前升高,CD3+、CD8+较治疗前下降(P<0.05);且观察组CD3+、CD4+、CD4+/ CD8+高于对照组,CD8+低于对照组(P<0.05)。治疗后,2 组血清TLR4、MyD88、NF-κB 水平较治疗前降 低(P<0.05),且观察组血清TLR4、MyD88、NF-κB水平低于对照组(P<0.05)。结论:橘红胶囊联合阿奇 霉素治疗MPP患儿痰热闭肺证的疗效明显,能促进患儿症状体征与中医证候的好转,提高患儿免疫功能,并 有效抑制TLR4/MyD88/NF-κB炎症通路。

    Abstract:

    Abstract: Objective: To observe the curative effect of Juhong Capsules combined with Azithromycin on children with mycoplasma pneumoniae pneumonia (MPP) with syndrome of phlegm-heat blocking the lung and its effect on the levels of serum toll-like receptor 4 (TLR4) , myeloid differentiation factor 88 (MyD88) and nuclear transcription factor κB (NF- κB). Methods: A total of 82 MPP children were selected and divided into the control group and the observation group by random number table method, with 41 cases in each group. The control group was treated with sequential regimen of Azithromycin,and the observation group was additionally treated with Juhong Capsules based on the treatment of the control group. They were treated for two weeks. The clinical effects,disappearance time of symptoms and signs, scores of syndrome of phlegm-heat blocking the lung,and levels of serum T cell subsets,TLR4,MyD88 and NF- κB were compared between the two groups. Results: After two-week treatment, the total effective rate was 97.56% in the observation group,higher than that of 80.49% in the control group (P< 0.05). The disappearance time of fever, lung moist rales and cough in the observation group was shorter than that in the control group (P<0.05). After treatment,each score of syndrome of phlegm-heat blocking the lung in the two groups was reduced when compared with that before treatment (P<0.05), and each syndrome score in the observation group was lower than that in the control group (P<0.05). After treatment,the levels of CD4+ and CD4+/CD8+ in the two groups were increased when compared with those before treatment, while the levels of CD3+ and CD8+ were lower than those before treatment (P<0.05); the levels of CD3+ and CD4+ and CD4+/CD8+ in the observation group were higher than those in the control group, and the levels of CD8+ was lower than those in the control group (P<0.05). After treatment, the levels of serum TLR4,MyD88 and NF-κB in both groups were reduced when compared with those before treatment (P<0.05), and the levels of serum TLR4, MyD88 and NF- κB in the observation group were lower than those in the control group (P<0.05). Conclusion: The therapy of Juhong Capsules combined with Azithromycin has an obvious curative effect on MPP children with syndrome of phlegm-heat blocking the lung, which can promote the improvement of symptoms, signs and traditional Chinese medicine syndromes, enhance their immune function, and effectively inhibit TLR4/MyD88/NF- κB inflammatory pathway.

    参考文献
    相似文献
    引证文献
引用本文

陈书挪,毛少艳.橘红胶囊联合阿奇霉素治疗肺炎支原体肺炎患儿痰热闭肺证临床研究[J].新中医,2024,56(17):88-92

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-09-11
  • 出版日期:
文章二维码